SCHEELE LABORATORIES PHILS., INC. Doxalin Doxycycline (As Hyclate) Philippines - English - FDA (Food And Drug Administration)

scheele laboratories phils., inc. doxalin doxycycline (as hyclate)

scheele laboratories phils., inc. - drug - doxycycline (as hyclate) - doxalin

Ritemed Phils., Inc. Tin Number: 207-644-204-000 None Doxycycline (As Hyclate) Philippines - English - FDA (Food And Drug Administration)

ritemed phils., inc. tin number: 207-644-204-000 none doxycycline (as hyclate)

scheele laboratories phils., inc. - drug - doxycycline (as hyclate) - none

None Dosage 500 mg (equivalent to 562.43 mg Sodium ascorbate) 1,000 IU/10 mg (equivalent to 70 mg Zinc gluconate) Dosage Philippines - English - FDA (Food And Drug Administration)

none dosage 500 mg (equivalent to 562.43 mg sodium ascorbate) 1,000 iu/10 mg (equivalent to 70 mg zinc gluconate) dosage

metz pharmaceuticals, inc. - ascorbic acid , cholecalciferol , zinc - capsule classification: over-the-counter (otc) - 500 mg (equivalent to 562.43 mg sodium ascorbate) 1,000 iu/10 mg (equivalent to 70 mg zinc gluconate) dosage

Dianeal PD-2 Solution for Intraperitoneal Administration (Dialysis) Philippines - English - FDA (Food And Drug Administration)

dianeal pd-2 solution for intraperitoneal administration (dialysis)

 ; importer:  ; distributor: baxter healthcare phils., inc. - peritoneal dialysis solution with 4.25% dextrose - solution for intraperitoneal administration (dialysis) - formulation: each 100ml contains: dextrose hydrous sodium chloride sodium lactate calcium chloride dihydrate magnesium chloride hexahydrate 4.25 g 538 mg 448 mg 25.7 mg 5.08 mg

BAXTER POTASSIUM CHLORIDE 40 mmol and 0.9% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 40 mmol and 0.9% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 29.8 g/l; sodium chloride, quantity: 9 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 10 mmol and 0.29% SODIUM CHLORIDE 100 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 10 mmol and 0.29% sodium chloride 100 ml intravenous infusion bag

baxter healthcare pty ltd - sodium chloride, quantity: 2.92 g/l; potassium chloride, quantity: 7.46 g/l - injection, intravenous infusion - excipient ingredients: water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

ZINC- zinc chloride injection, solution United States - English - NLM (National Library of Medicine)

zinc- zinc chloride injection, solution

hospira, inc. - zinc chloride (unii: 86q357l16b) (zinc cation - unii:13s1s8sf37) - zinc cation 1 mg in 1 ml - zinc 1 mg/ml (zinc chloride injection, usp) is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition. administration helps to maintain zinc serum levels and to prevent depletion of endogenous stores, and subsequent deficiency symptoms. none known. none known.

ZINC SULFATE injection, solution United States - English - NLM (National Library of Medicine)

zinc sulfate injection, solution

american regent, inc. - zinc sulfate anhydrous (unii: 0j6z13x3wo) (zinc cation - unii:13s1s8sf37) - zinc cation 1 mg in 1 ml - zinc sulfate injection, usp is indicated for use as a supplement to intravenous solutions given for tpn. administration helps to maintain plasma levels and to prevent depletion of endogenous stores. zinc sulfate injection, usp should not be given undiluted by direct injection into a peripheral vein because of the likelihood of infusion phlebitis and the potential to increase renal loss of zinc from a bolus injection.

BAXTER POTASSIUM CHLORIDE 30 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 30 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 2.24 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.

BAXTER POTASSIUM CHLORIDE 20 mmol and 0.9% SODIUM CHLORIDE 1000 mL intravenous infusion bag Australia - English - Department of Health (Therapeutic Goods Administration)

baxter potassium chloride 20 mmol and 0.9% sodium chloride 1000 ml intravenous infusion bag

baxter healthcare pty ltd - potassium chloride, quantity: 1.5 g/l; sodium chloride, quantity: 9 g/l - injection, solution - excipient ingredients: hydrochloric acid; water for injections - the baxter potassium chloride and sodium chloride intravenous infusion is indicated as a source of water and to restore electrolyte balance as required by the patient's clinical condition, such as hypokalaemia.